Genetics of Changes in Population Pyramids: Implications for Health Forecasting

人口金字塔变化的遗传学：对健康预测的影响

• 批准号: 8788246
• 负责人: ANATOLIY I YASHIN
• 金额: $ 56.47万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8788246
• 关键词: Accounting; Address; Affect; Age; Alzheimer' s Disease; Birth; Comorbidity; Coronary heart disease; Data; Data Set; Diabetes Mellitus; Disease; Education; Elderly; Female; Framingham Heart Study; Future; Gender; Genes; Genetic; Genomic Segment; Habits; Health; Health Transition; Healthcare Systems; Human Genome; Individual; Internet; Link; Literature; Long-Term Care; Longevity; Malignant Neoplasms; Marital Status; Medical Surveillance; Medicare; Metabolic Pathway; Modeling; Mutation; Pattern; Physiological; Population; Prevalence; Race; Recommendation; Records; Research; Resources; Retirement; Risk; Risk Estimate; Role; Signal Pathway; Smoking; Specific qualifier value; Stroke; Surveys; Testing; Time; Uncertainty; age related; cohort; data modeling; drinking; functional improvement; genetic association; genetic information; genetic variant; improved; indexing; male; mortality; non-genetic; population health; trait; trend

DESCRIPTION (provided by applicant): The overall objective of the proposed research is to significantly improve quality of health forecasting for the US elderly. This objective will be reached by constructing a set of new health predicting models having different levels of complexity, evaluating quality of their predictions, and using verified models to predict future prevalence of cancer, coronary heart disease (CHD), stroke, diabetes, and Alzheimer's disease (AD) under different scenarios. The models will use information about factors affecting health and survival available in five datasets including the Framingham Heart Study (FHS), Health and Retirement study merged with Medicare files (HRS-M), National Long Term Care Survey linked to Medicare records (NLTCS-M), the Surveillance, the Epidemiology and End Results data merged with Medicare records (SEER-M), and the 5% Medicare (5%-M) file. The most sophisticated models will use information about genetic and non-genetic factors, and take pleiotropic, polygenic, and age-specific effects of genes on health and survival, as well as dynamic mechanisms of aging related changes, into account. The following specific aims will be addressed: 1. Predict age patterns of prevalence for cancer, CHD, stroke, diabetes, and AD for years 2020, 2025, 2030, and 2035 using models having different levels of complexity constructed using data from SEER-M, and 5%-M files, NLTCS-M and HRS-M (without genetic data) for males and females under different scenarios.2. Identify sets of genetic variants showing individual and pleiotropic associations with health and survival traits in the FHS and HRS-M data using candidate genomic regions enriched for pleiotropic genetic effects on health traits. Identify genes related to selected genetic variants and evaluate their roles in metabolic and signaling pathways and disease networks. Construct polygenic score indices and evaluate their influence on health and survival traits. 3. Predict age patterns of prevalence for the same diseases and time horizons as in Aim 1, however applying advanced modeling approaches incorporating the genetic information about pleiotropic, polygenic and age-specific effects of genetic variants on health and survival and using different scenarios. Test the quality of health predictions using subsets of available data. Use verified models in health forecasting for time horizons specified above. 4. Predict age patterns of prevalence of diseases listed above using extended multistate health and mortality models by considering risks of health transitions as functions of genetic factors, as well as observed covariates and physiological variables. For these purposes, evaluate risks of transitions and their time trends for subsequent birth cohorts using FHS and HRS-M data. Test quality of health predictions using subsets of available data. Use verified models in health forecasting under different scenarios. Compare results of health predictions using different models constructed in this project, as well as models available in the literature. Make recommendations concerning the proper use of data and models in health forecasting for time horizons specified above.

描述（由申请人提供）：拟议研究的总体目标是显着提高美国老年人健康预测的质量。通过构建一套具有不同复杂程度的新健康预测模型，评估其预测质量，并使用经过验证的模型来预测癌症、冠心病（CHD）、中风、糖尿病和阿尔茨海默病的未来患病率，可以实现这一目标不同情况下的疾病（AD）。这些模型将使用五个数据集中有关影响健康和生存的因素的信息，包括弗雷明汉心脏研究 (FHS)、与医疗保险文件合并的健康和退休研究 (HRS-M)、与医疗保险记录相关的国家长期护理调查 (NLTCS- M)、监测、流行病学和最终结果数据与医疗保险记录 (SEER-M) 合并，以及 5% 医疗保险 (5%-M) 文件。最复杂的模型将使用有关遗传和非遗传因素的信息，并考虑基因对健康和生存的多效性、多基因性和年龄特异性影响，以及衰老相关变化的动态机制。将解决以下具体目标： 1. 使用 SEER-M 数据构建的具有不同复杂程度的模型，预测 2020、2025、2030 和 2035 年癌症、CHD、中风、糖尿病和 AD 患病率的年龄模式，以及不同场景下男性和女性的5%-M文件、NLTCS-M和HRS-M（无遗传数据）。2．使用富含对健康性状的多效性遗传效应的候选基因组区域，识别 FHS 和 HRS-M 数据中显示与健康和生存性状的个体和多效性关联的遗传变异组。识别与选定遗传变异相关的基因，并评估它们在代谢和信号通路以及疾病网络中的作用。构建多基因评分指数并评估其对健康和生存特征的影响。 3. 预测与目标 1 中相同的疾病和时间范围的患病年龄模式，但应用先进的建模方法，结合有关遗传变异对健康和生存的多效性、多基因性和年龄特异性影响的遗传信息，并使用不同的场景。使用可用数据子集测试健康预测的质量。在上面指定的时间范围内使用经过验证的模型进行健康预测。 4. 通过将健康转变风险视为遗传因素以及观察到的协变量和生理变量的函数，使用扩展的多州健康和死亡率模型来预测上述疾病流行的年龄模式。为此，使用 FHS 和 HRS-M 数据评估后续出生队列的转变风险及其时间趋势。使用可用数据子集测试健康预测的质量。使用经过验证的模型进行不同场景下的健康预测。使用本项目中构建的不同模型以及文献中可用的模型来比较健康预测的结果。就上述时间范围内的健康预测中正确使用数据和模型提出建议。